Previous 10 | Next 10 |
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive ...
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasi...
VANCOUVER, Dec. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN): NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minima...
Vancouver, British Columbia and Berlin, Germany--(Newsfile Corp. - November 26, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minim...
The following slide deck was published by Neovasc Inc. in conjunction with this Read more ...
- Educational events featuring the Reducer hosted in Germany and Italy - VANCOUVER, CA, COBURG, DE, and COTIGNOLA, IT, Nov. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN), a leader in the development ...
Vancouver, British Columbia--(Newsfile Corp. - November 19, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive device...
Vancouver, British Columbia and Mainz, Germany--(Newsfile Corp. - November 12, 2019) - Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minima...
Start Time: 16:30 End Time: 17:00 Neovasc, Inc. (NVCN) Q3 2019 Earnings Conference Call November 07, 2019, 16:30 PM ET Company Participants Fred Colen - President and CEO Chris Clark - CFO Mike Cavanaugh - Westwicke/ICR Conference Call Participants Danielle Antalffy - S...
Recent Highlights Delivered continued revenue growth for Neovasc Reducer TM ("Reducer") Reducer added to the European Society of Cardiology Practice Guidelines for the treatment of refractory angina Reducer featured at the 40th Annual National Congress of the Italian Society ...
News, Short Squeeze, Breakout and More Instantly...
Neovasc Inc. (NASDAQ: NVCN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.48% on the day to $29.23. Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. It...
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fourth quarter and year ended December 31, 2022. Recent Hi...
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as d...